Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 16

1.

Cumulative risk of Guillain-Barré syndrome among vaccinated and unvaccinated populations during the 2009 H1N1 influenza pandemic.

Vellozzi C, Iqbal S, Stewart B, Tokars J, DeStefano F.

Am J Public Health. 2014 Apr;104(4):696-701. doi: 10.2105/AJPH.2013.301651. Epub 2014 Feb 13.

2.

Guillain-Barré syndrome surveillance during National Influenza Vaccination Campaign, New York, U.S.A., 2009.

Giambrone GP, Zansky SM, Eidson M, Duncan PG, McNutt LA, Birkhead GS.

Emerg Infect Dis. 2013 Dec;19(12):1956-62. doi: 10.3201/eid1912.130643.

3.

Guillain-Barré Syndrome, Influenza Vaccination, and Antecedent Respiratory and Gastrointestinal Infections: A Case-Centered Analysis in the Vaccine Safety Datalink, 2009-2011.

Greene SK, Rett MD, Vellozzi C, Li L, Kulldorff M, Marcy SM, Daley MF, Belongia EA, Baxter R, Fireman BH, Jackson ML, Omer SB, Nordin JD, Jin R, Weintraub ES, Vijayadeva V, Lee GM.

PLoS One. 2013 Jun 26;8(6):e67185. doi: 10.1371/journal.pone.0067185. Print 2013.

4.

Review of Gardasil.

Harper DM, Vierthaler SL, Santee JA.

J Vaccines Vaccin. 2010 Nov 23;1(107). pii: 1000107.

5.

Guillain-Barré syndrome and variants.

Dimachkie MM, Barohn RJ.

Neurol Clin. 2013 May;31(2):491-510. doi: 10.1016/j.ncl.2013.01.005. Epub 2013 Feb 19. Review.

6.

Risk of Guillain-Barré syndrome after 2010-2011 influenza vaccination.

Galeotti F, Massari M, D'Alessandro R, Beghi E, Chiò A, Logroscino G, Filippini G, Benedetti MD, Pugliatti M, Santuccio C, Raschetti R; ITANG study group.

Eur J Epidemiol. 2013 May;28(5):433-44. doi: 10.1007/s10654-013-9797-8. Epub 2013 Mar 31.

7.

Safety of AS03-adjuvanted split-virion H1N1 (2009) pandemic influenza vaccine: a prospective cohort study.

Nazareth I, Tavares F, Rosillon D, Haguinet F, Bauchau V.

BMJ Open. 2013 Feb 5;3(2). pii: e001912. doi: 10.1136/bmjopen-2012-001912. Print 2013.

8.

The impact of influenza vaccinations on the adverse effects and hospitalization rate in the elderly: a national based study in an Asian country.

Ho TY, Huang KY, Huang TT, Huang YS, Ho HC, Chou P, Lin CH, Wei CK, Lian WC, Chen TC, Huang HB, Lee CC.

PLoS One. 2012;7(11):e50337. doi: 10.1371/journal.pone.0050337. Epub 2012 Nov 28.

9.

Surveillance for Guillain-Barré syndrome after influenza vaccination among the Medicare population, 2009-2010.

Burwen DR, Sandhu SK, MaCurdy TE, Kelman JA, Gibbs JM, Garcia B, Markatou M, Forshee RA, Izurieta HS, Ball R; Safety Surveillance Working Group.

Am J Public Health. 2012 Oct;102(10):1921-7. Epub 2012 Feb 16.

10.

Guillain-Barre syndrome during the 2009-2010 H1N1 influenza vaccination campaign: population-based surveillance among 45 million Americans.

Wise ME, Viray M, Sejvar JJ, Lewis P, Baughman AL, Connor W, Danila R, Giambrone GP, Hale C, Hogan BC, Meek JI, Murphree R, Oh JY, Reingold A, Tellman N, Conner SM, Singleton JA, Lu PJ, DeStefano F, Fridkin SK, Vellozzi C, Morgan OW.

Am J Epidemiol. 2012 Jun 1;175(11):1110-9. doi: 10.1093/aje/kws196. Epub 2012 May 11.

11.

Phase 2 assessment of the safety and immunogenicity of two inactivated pandemic monovalent H1N1 vaccines in adults as a component of the U.S. pandemic preparedness plan in 2009.

Chen WH, Winokur PL, Edwards KM, Jackson LA, Wald A, Walter EB, Noah DL, Wolff M, Kotloff KL; Pandemic H1N1 Vaccine Adult Study Group.

Vaccine. 2012 Jun 13;30(28):4240-8. doi: 10.1016/j.vaccine.2012.04.044. Epub 2012 Apr 23.

12.

Two years after pandemic influenza A/2009/H1N1: what have we learned?

Cheng VC, To KK, Tse H, Hung IF, Yuen KY.

Clin Microbiol Rev. 2012 Apr;25(2):223-63. doi: 10.1128/CMR.05012-11. Review.

13.

Guillain-Barre syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccine: multinational case-control study in Europe.

Dieleman J, Romio S, Johansen K, Weibel D, Bonhoeffer J, Sturkenboom M; VAESCO-GBS Case-Control Study Group.

BMJ. 2011 Jul 12;343:d3908. doi: 10.1136/bmj.d3908.

14.

Estimating background rates of Guillain-Barré Syndrome in Ontario in order to respond to safety concerns during pandemic H1N1/09 immunization campaign.

Deeks SL, Lim GH, Simpson MA, Rosella L, Mackie CO, Achonu C, Crowcroft NS.

BMC Public Health. 2011 May 17;11:329. doi: 10.1186/1471-2458-11-329.

15.

The 2009 pandemic H1N1 influenza vaccination in France: who accepted to receive the vaccine and why?

Raude J, Caille-Brillet AL, Setbon M.

PLoS Curr. 2010 Oct 19;2:RRN1188. doi: 10.1371/currents.RRN1188.

16.

Reflections on pandemic (H1N1) 2009 and the international response.

Leung GM, Nicoll A.

PLoS Med. 2010 Oct 5;7(10). pii: e1000346. doi: 10.1371/journal.pmed.1000346. Review. No abstract available.

Supplemental Content

Support Center